// App-Quantinova.ai

Abstract 12334 : Concerns About the Use of Digoxin in Acute Coronary Syndromes

Researchers

Presenter

  • Edina Cenko

Principal Investigators

  • Maria Bergami

  • Jinsung Yoon

  • Mihaela van der Schaar

  • Sasko Kedev

  • Chris P Gale

  • Zorana Vasiljevic

  • Davor Milicic

  • Marija Zdravkovic

  • Gordana Krljanac

  • Lina Badimon

  • Olivia Manfrini

  • Raffaele Bugiardini

Medical Centers

  • Univ of Leeds, Leeds

  • Institute for Cardiovascular Diseases, Clinical Center of Serbia, Belgrade, Serbia

  • Universiy Cardiovascular Clinic, Zagreb

  • CARDIOVASCULAR PROGRAM ICCC-IRHSCSP, Barcelona

  • UNIVERSITY OF Belgrade, Belgrade, Serbia

  • UNIVERSITY OF BOLOGNA, Bologna, Italy

  • Univ Clinical Hosp Cntr Bezanijska Kosa, Faculty of Medicine, Univ of Belgrade, Serbia., Belgrade, Serbia

  • Dept of Experimental, Diagnostic and Specialty Medicine, Google Cloud AI, Sunnyvale, CA

  • Dept of Experimental, Diagnostic and Specialty Medicine, UNIVERSITY OF BOLOGNA, Bologna, Italy

  • Castel San Pietro Terme, Italy

  • Univ Clinic of Cardiology, Skopje

Locations

  • United Kingdom

  • Serbia

  • Croatia

  • Venezuela

  • Italy

  • United States

  • Macedonia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Heart muscle disease

Biomarkers

  • N/A

Drug/Treatment

  • Digoxin

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • NCT04008173

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved